» Authors » Michelle Nuno

Michelle Nuno

Explore the profile of Michelle Nuno including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 8
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Aslanyan V, Pickering T, Nuno M, Renfro L, Pa J, Mack W
Pharm Stat . 2024 Oct; 24(2):e2443. PMID: 39444356
Study designs incorporate interim analyses to allow for modifications to the trial design. These analyses may aid decisions regarding sample size, futility, and safety. Furthermore, they may provide evidence about...
2.
Dupuis L, Fisher B, Sugalski A, Grimes A, Nuno M, Ramakrishnan S, et al.
Pediatr Blood Cancer . 2024 Jan; 71(4):e30880. PMID: 38291716
Background: The primary objective was to measure the proportion of episodes where care delivery was inconsistent with selected recommendations of a clinical practice guideline (CPG) on fever and neutropenia (FN)...
3.
Wolfson J, Grimes A, Nuno M, Kerber C, Ramakrishnan S, Beauchemin M, et al.
JCO Oncol Pract . 2024 Jan; 20(4):491-502. PMID: 38252911
Purpose: Individuals diagnosed with cancer between 15 and 39 years (adolescent and young adult [AYA]) face unique vulnerability. Detail is lacking about care delivery for these patients, especially those with...
4.
Lafin J, Scarpini C, Amini A, Konneh B, Howard J, Gerald T, et al.
Sci Rep . 2023 Jun; 13(1):10558. PMID: 37386046
Circulating miR-371a-3p has excellent performance in the detection of viable (non-teratoma) germ cell tumor (GCT) pre-orchiectomy; however, its ability to detect occult disease is understudied. To refine the serum miR-371a-3p...
5.
Lafin J, Scarpini C, Amini A, Konneh B, Howard J, Gerald T, et al.
Res Sq . 2023 Mar; PMID: 36993198
Circulating miR-371a-3p has excellent performance in the detection of viable (non-teratoma) GCT pre-orchiectomy; however, its ability to detect occult disease is understudied. To refine the serum miR-371a-3p assay in the...
6.
Lone D, Sadak K, Miller B, Sample J, Hubbard A, Wolter C, et al.
J Endocrinol Metab . 2022 Oct; 12(3):79-88. PMID: 36249955
Background And Aims: Intracranial germ cell tumor (iGCT) survivors have multiple risk factors for growth hormone (GH) deficiency, a commonly reported late effect in childhood cancer survivors. The objective of...